Printer Friendly

ALK-Abello A/S posts 9-month EBIT of DKK131m.

NORDIC BUSINESS REPORT-4 July 2006-ALK-Abello A/S posts 9-month EBIT of DKK131m(C)1994-2006 M2 COMMUNICATIONS LTD

The Danish allergy diagnostics and vaccines company ALK-Abello A/S issued on Tuesday (4 July) its report for the first nine months of the financial year 2005/2006, posting an operating profit (EBIT) of DKK131m, as compared to DKK34m in the first nine months of 2004/2005.

Revenues for the period amounted to DKK1,160m, up from DKK913m in the corresponding period a year earlier.

One Danish krone (DKK) is worth approximately 0.09 British pounds (GBP).

((Comments on this story may be sent to

COPYRIGHT 2006 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nordic Business Report
Article Type:Brief article
Geographic Code:4EUDE
Date:Jul 4, 2006
Previous Article:SKF completes acquisition of French bearings manufacturer SNFA SAS.
Next Article:Poyry Plc wins EUR17m engineering contract in Abu Dhabi.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |